This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Keybanc analyst Ashley Owens downgraded the rating for Deckers Outdoor Corporation DECK from Overweight to Sector Weight. Deckers Outdoor shares closed at $126.09 on Thursday. See how other analysts view this stock.
• Compass Point analyst Giuliano Bologna downgraded Radian Group Inc. RDN from Buy to Neutral but raised the price target from $34 to $37. Radian Group shares closed at $33.66 on Thursday. See how other analysts view this stock.
• Maxim Group analyst Jason McCarthy downgraded the rating for Citius Pharmaceuticals, Inc. CTXR from Buy to Hold. Citius Pharmaceuticals shares closed at $0.7240 on Thursday. See how other analysts view this stock.
• Raymond James analyst Wilma Burdis downgraded Reinsurance Group of America, Incorporated RGA from Strong Buy to Market Perform. Reinsurance Group shares closed at $202.89 on Thursday. See how other analysts view this stock.
• Maxim Group analyst Michael Okunewitch downgraded Citius Oncology, Inc. CTOR from Buy to Hold. Citius Oncology shares closed at $0.9090 on Thursday. See how other analysts view this stock.

Considering buying DECK stock? Here’s what analysts think:

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

Read This Next:

• Jim Cramer Says Medical Properties Trust Has ‘Too Much Risk,’ Likes This Industrial Stock

Photo via Shutterstock